Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians

Tissue Antigens

Volumn 58, Issue 1, 2001, Pages 50-54

  Milicic, A ^a   Brown, M A ^a   Wordsworth, B P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Association; CTLA 4; Rheumatoid arthritis; SNP

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE;

ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENE LOCUS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; UNITED KINGDOM;

ADENOSINE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ARTHRITIS, RHEUMATOID; CODON; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; GUANOSINE; HUMANS; IMMUNOCONJUGATES; POLYMORPHISM, GENETIC;

EID: 0034793528     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2001.580110.x     Document Type: Article

References (31)

1. Investigation of candidate disease susceptibility genes in rheumatoid arthritis: Principles and strategies
2. Polygenic susceptibility to rheumatoid arthritis
3. Lymphocytes, polymorphonuclear leukocytes, macrophages and platelets in synovium involved by rheumatoid arthritis. A study with mononuclear antibodies
4. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
5. CTLA-4 can function as a negative regulator of T-cell activation
6. The emerging role of CTLA-4 as immune attenuator
7. A CTLA4 polymorphism affects lymphocyte mRNA levels but is not associated with type-1 diabetes in a Canadian dataset
8. Study of CTLA-4 gene expression in patients with IDDM
9. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus
10. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33
11. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes
12. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups
13. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
14. The CTLA-4 gene is associated with multiple sclerosis
15. CTLA-4 polymorphism and susceptibility to juvenile rheumatoid arthritis (JRA)
16. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis
17. CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis
18. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
19. Estimating genotype relative risks
20. Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency
21. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
22. Treatment of murine lupus with CTLA4Ig
23. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: Requirement for both B7-1 and B7-2
24. CTLA-4 in autoimmune disease - A general susceptibility gene to autoimmunity?
25. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
26. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes melitus
27. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families
28. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: An association study using a novel variation screening method
29. A single nucleotide polymorphism in exon 1 of cytotoxic T lymphocyte-assodated antigen-4 (CTLA4) is not associated with rheumatoid arthritis
30. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study